venetoclax,ibrutinib
abbvie,janssen,roche
[' ibru', 'lymsm', 'venetoclax']
patients with previously untreated waldenstr m macroglobulinemia a rare form of blood cancer derived fast and durable responses after receiving treatment with ibrutinib plus venetoclax. #lymsm #ash22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.